Clinical trial NCT04517422 - References

SARS-CoV Infection — Efficacy of L. Plantarum and P. Acidilactici in Adults With SARS-CoV-2 and COVID-19

Citation(s)

•   Aktas B, Aslim B
  Gut-lung axis and dysbiosis in COVID-19. Turk J Biol. 2020 Jun 21;44(3):265-272. doi: 10.3906/biy-2005-102. eCollection 2020.
•   Bottari B, Castellone V, Neviani E
  Probiotics and Covid-19. Int J Food Sci Nutr. 2021 May;72(3):293-299. doi: 10.1080/09637486.2020.1807475. Epub 2020 Aug 12. Review.
•   d'Ettorre G, Ceccarelli G, Marazzato M, Campagna G, Pinacchio C, Alessandri F, Ruberto F, Rossi G, Celani L, Scagnolari C, Mastropietro C, Trinchieri V, Recchia GE, Mauro V, Antonelli G, Pugliese F, Mastroianni CM
  Challenges in the Management of SARS-CoV
•   De Maio F, Posteraro B, Ponziani FR, Cattani P, Gasbarrini A, Sanguinetti M
  Nasopharyngeal Microbiota Profiling of SARS-CoV-2 Infected Patients. Biol Proced Online. 2020 Jul 25;22:18. doi: 10.1186/s12575-020-00131-7. eCollection 2020.
•   Klann E, Rich S, Mai V
  Gut microbiota and COVID-19: A superfluous diagnostic biomarker or therapeutic target? Clin Infect Dis. 2020 Aug 11. pii: ciaa1191. doi: 10.1093/cid/ciaa1191. [Epub ahead of print]
•   Marcialis MA, Bardanzellu F, Fanos V
  Microbiota and Covid-19. Which came first, the chicken or the egg? Clin Infect Dis. 2020 Jul 10. pii: ciaa965. doi: 10.1093/cid/ciaa965. [Epub ahead of print]
•   Villena J, Kitazawa H
  The Modulation of Mucosal Antiviral Immunity by Immunobiotics: Could They Offer Any Benefit in the SARS-CoV-2 Pandemic? Front Physiol. 2020 Jun 16;11:699. doi: 10.3389/fphys.2020.00699. eCollection 2020. Review.
•   Zuo T, Liu Q, Zhang F, Lui GC, Tso EY, Yeoh YK, Chen Z, Boon SS, Chan FK, Chan PK, Ng SC
  Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19. Gut. 2021 Feb;70(2):276-284. doi: 10.1136/gutjnl-2020-322294. Epub 2020 Jul 20.

Efficacy and Safety of Lactobacillus Plantarum and Pediococcus Acidilactici as Co-adjuvant Therapy for Reducing the Risk of Severe Disease in Adults With SARS-CoV-2 and Its Modulation of the Fecal Microbiota: A Randomized Clinical Trial

Details for clinical trial NCT04517422